Connect your AI

Opko Health OPK Proceeds from disposal of certain strategic investments

Proceeds from disposal of certain strategic investments at other companies

Bristol-Myers SquibbBMY

$391M+3,158%

Merck & Co.MRK

——

Other financials

Income statement

Revenue$124.2M-17.2%

Gross profit$45.8M+7.4%

Operating income-$51.0M+24.0%

Net income-$54.8M+18.9%

EPS (diluted)-$0.07+30.0%

Balance sheet

Cash & equivalents$40.6M-62.5%

Total debt$52.8M-4.2%

Total equity$1.2B-8.2%

Total assets$1.9B-12.8%

Cash flow

Operating cash flow-$19.3M+44.1%

CapEx$1.8M-42.6%

Free cash flow-$21.1M+44.0%

Valuation

Market cap$1.13B+11.5%

P/S1.9×+0.5×

Profitability

Gross margin36%+4.2pp

Operating margin-17.4%-5.6pp

Net margin-36.6%-44.8pp

FCF margin-30%+0.1pp

Returns & leverage

Return on equity-16.9%-21.7pp

Debt / equity0×0.0×

Current ratio3.6×+1.1×

Where this comes from

Reported directly by Opko Health in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfEquitySecuritiesFvNi.

The official record: Opko Health’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Opko Health's proceeds from disposal of certain strategic investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Opko Health's proceeds from disposal of certain strategic investments?: Opko Health (OPK) reported proceeds from disposal of certain strategic investments of $0 in Q1 2026.
How has Opko Health's proceeds from disposal of certain strategic investments changed year-over-year?: Opko Health's proceeds from disposal of certain strategic investments decreased by 100.0% year-over-year, from $51.66M to $0.